PERFORMANCE OF AI-GENERATED DRUG–DRUG INTERACTION ALERTS VERSUS PHARMACIST ASSESSMENT: A SYSTEMATIC REVIEW
Universal Journal of Pharmaceutical Research · 15.07.2026
DOI: 10.22270/ujpr.v11i3.1575 ↗Kurz gefasst
Systematische Übersicht in der Zeitschrift Universal Journal of Pharmaceutical Research, online erschienen am 15.07.2026. Verfasst von Seerat Shahzad und 7 weiteren Autor:innen. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).
Abstract (Originalsprache)
Background
Artificial Intelligence (AI) is increasingly being used in the medicine administration and drug–drug interaction (DDI) screening domain in healthcare. However, its reliability in comparison with the pharmacist review is unknown. This systematic review aimed to compare the effectiveness of DDI alerts generated by AI to DDI alerts generated by pharmacists. Methodology: This review was done in accordance with PRISMA 2020 guidelines and registered with PROSPERO (CRD420251153581). The publications since 2022 were obtained from PubMed, Embase, Scopus, Web of Science, Cochrane Library, IEEE Xplore, and arXiv. The Mixed Methods Appraisal Tool (MMAT) 2018 was used to evaluate the quality of the studies.
Results
Fourteen studies of AI systems like ChatGPT, Gemini, Bing AI, and Claude were selected. AI models performed well in general drug information retrieval and were found to have significant shortcomings when it comes to clinical DDI screening. Low accuracy, inconsistent responses, severity and onset not assessed and clinically important interaction not included were common problems. Pharmacist review and validated databases like Lexicomp and Micromedex were more reliable to assess DDI.
Conclusion
AI systems can provide support for drug information and may be suitable but are currently not sufficient for autonomous drug information screening. However, pharmacist oversight will remain essential to patient safety, and additional studies are required to develop customizable AI systems for pharmacies that incorporate trusted clinical decision support tools. Peer Review History: Received 9 April 2026; Reviewed 11 May 2026; Accepted 13 June; Available online 15 July 2026 Academic Editor: Dr. Sally A. El-Zahaby, Pharos University in Alexandria, Egypt, sally.elzahaby@yahoo.com Reviewers: Dr. Esther Marguerite Chase DJANGA, Faculty of Medicine and Biomedical Sciences. Department of Public Health. University of Yaoundé I, Cameroon. e.djanga@yahoo.com Dr. Dennis Amaechi, MrsFoluBabade Mini Estate , Flat 5 by Old Soldiers Quarter, Sabongari/Bwari, Abuja- Federal Capital Territory, Nigeria. amaechitoexcel@yahoo.com
Zitieren
APA
Shahzad, S., Afzaal, A., Afzaal, R., Ashraf, A., Bilal, H. M., Zaidi, S. H. H., Abid, A. R., & Shahzad, Z. (2026). PERFORMANCE OF AI-GENERATED DRUG–DRUG INTERACTION ALERTS VERSUS PHARMACIST ASSESSMENT: A SYSTEMATIC REVIEW. Universal Journal of Pharmaceutical Research. https://doi.org/10.22270/ujpr.v11i3.1575
Vancouver
Shahzad S, Afzaal A, Afzaal R, Ashraf A, Bilal HM, Zaidi SHH, et al. PERFORMANCE OF AI-GENERATED DRUG–DRUG INTERACTION ALERTS VERSUS PHARMACIST ASSESSMENT: A SYSTEMATIC REVIEW. Universal Journal of Pharmaceutical Research. 2026. doi:10.22270/ujpr.v11i3.1575
BibTeX
@article{Shahzad2026,
author = {Shahzad, Seerat and Afzaal, Ayesha and Afzaal, Rida and Ashraf, Asma and Bilal, Hafiz Muhammad and Zaidi, Syed Hamid Hussain and Abid, Abdul Rehman and Shahzad, Zarfshan},
title = {PERFORMANCE OF AI-GENERATED DRUG–DRUG INTERACTION ALERTS VERSUS PHARMACIST ASSESSMENT: A SYSTEMATIC REVIEW},
journal = {Universal Journal of Pharmaceutical Research},
year = {2026},
doi = {10.22270/ujpr.v11i3.1575}
}
EUVIMED